Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
- PMID: 16495932
- PMCID: PMC2361198
- DOI: 10.1038/sj.bjc.6602989
Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy
Abstract
Gastro-oesophageal cancer is associated with a high incidence of cachexia. Proteolysis-inducing factor (PIF) has been identified as a possible cachectic factor and studies suggest that PIF is produced exclusively by tumour cells. We investigated PIF core peptide (PIF-CP) mRNA expression in tumour and benign tissue from patients with gastro-oesophageal cancer and in gastro-oesophageal biopsies for healthy volunteers. Tumour tissue and adjacent benign tissue were collected from patients with gastric and oesophageal cancer (n=46) and from benign tissue only in healthy controls (n=11). Expression of PIF-CP mRNA was quantified by real-time PCR. Clinical and pathological information along with nutritional status was collected prospectively. In the cancer patients, PIF-CP mRNA was detected in 27 (59%) tumour samples and 31 (67%) adjacent benign tissue samples. Four (36%) gastro-oesophageal biopsies from healthy controls also expressed PIF-CP mRNA. Expression was higher in tumour tissue (P=0.031) and benign tissue (P=0.022) from cancer patients compared with healthy controls. In the cancer patients, tumour and adjacent benign tissue PIF-CP mRNA concentrations were correlated with each other (P<0.0001, r=0.73) but did not correlate with weight loss or prognosis. Although PIF-CP mRNA expression is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy, expression does not relate to prognosis or cachexia. Post-translational modification of PIF may be a key step in determining the biological role of PIF in the patient with advanced cancer and cachexia.
Figures


Comment in
-
On the possible role of PIF in myofibrillar proteins mobilisation from skeletal muscles in the presence of non-malignant foci of growth in organism.Br J Cancer. 2008 Jan 15;98(1):242; author reply 243. doi: 10.1038/sj.bjc.6604116. Epub 2007 Nov 20. Br J Cancer. 2008. PMID: 18026185 Free PMC article. No abstract available.
Similar articles
-
Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.Br J Cancer. 2008 Jan 15;98(1):243. doi: 10.1038/sj.bjc.6604117. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087288 Free PMC article. No abstract available.
-
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.Br J Cancer. 2014 Mar 18;110(6):1525-34. doi: 10.1038/bjc.2014.45. Epub 2014 Feb 25. Br J Cancer. 2014. PMID: 24569475 Free PMC article.
-
The 'cancer cachectic factor'.Support Care Cancer. 2003 Feb;11(2):73-8. doi: 10.1007/s00520-002-0408-6. Epub 2002 Nov 5. Support Care Cancer. 2003. PMID: 12560934
-
Catabolic mediators of cancer cachexia.Curr Opin Support Palliat Care. 2008 Dec;2(4):256-61. doi: 10.1097/spc.0b013e328319d7fa. Curr Opin Support Palliat Care. 2008. PMID: 19069310 Review.
-
Cancer cachexia.Langenbecks Arch Surg. 2004 Aug;389(4):299-305. doi: 10.1007/s00423-004-0486-7. Epub 2004 May 28. Langenbecks Arch Surg. 2004. PMID: 15168125 Review.
Cited by
-
Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.Support Care Cancer. 2006 Dec;14(12):1173-83. doi: 10.1007/s00520-006-0097-7. Epub 2006 Jul 4. Support Care Cancer. 2006. PMID: 16819628 Review.
-
Cachexia in patients with oesophageal cancer.Nat Rev Clin Oncol. 2016 Mar;13(3):185-98. doi: 10.1038/nrclinonc.2015.200. Epub 2015 Nov 17. Nat Rev Clin Oncol. 2016. PMID: 26573424 Review.
-
On the possible role of PIF in myofibrillar proteins mobilisation from skeletal muscles in the presence of non-malignant foci of growth in organism.Br J Cancer. 2008 Jan 15;98(1):242; author reply 243. doi: 10.1038/sj.bjc.6604116. Epub 2007 Nov 20. Br J Cancer. 2008. PMID: 18026185 Free PMC article. No abstract available.
-
Reply: Expression of the proteolysis-inducing factor core-peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastrooesophageal malignancy.Br J Cancer. 2008 Jan 15;98(1):243. doi: 10.1038/sj.bjc.6604117. Epub 2007 Dec 18. Br J Cancer. 2008. PMID: 18087288 Free PMC article. No abstract available.
-
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines.Br J Cancer. 2008 Jul 8;99(1):126-32. doi: 10.1038/sj.bjc.6604458. Br J Cancer. 2008. PMID: 18594538 Free PMC article.
References
-
- Akerblom IE, Murry LE (1998) Human cachexia associated protein Incyte Pharmaceuticals Inc., Palo Alto, CA. US patent 628413(5,834,192)
-
- Bishop CW, Bowen PE, Ritchey SJ (1981) Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr 34: 2530–2539 - PubMed
-
- Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169–193 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous